Delivery Order SPE2DB22D3010-SPE2DB24FP1XK
Award Date
3/13/24
Potential Completion Date
3/14/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of XIFAXAN 550 mg tablets. The order has a total ceiling value of $12,216.97 and a performance period through March 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of XIFAXAN 550 MG TABLET 60S, a prescription pharmaceutical product. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a wide range of medical commodities to support military treatment programs and facilities worldwide. The delivery order has a ceiling value of $87,578.22 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XIFAXAN 550 mg tablets. The contract has a total ceiling value of $10,400.65 and a completion date of August 21, 2024. The award was made under an Indefinite Delivery Contract (IDC) that DLA Troop Support Medical holds with AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S, with a ceiling value of $25,484.40 and a period of performance through March 25, 2024. This order is issued under an existing indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The contract has a ceiling value of $28,160.03 and runs through January 9, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XIFAXAN 550 MG TABLET 60S. The contract has a ceiling value of $54,718.96 and an ultimate completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide XIFAXAN 550 MG TABLET 60S. The contract is a firm fixed-price delivery order with a ceiling value of $18,424.99 and a completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide XIFAXAN 550 MG TABLET 60S. The contract is a firm-fixed-price, non-set-aside delivery order with a ceiling value of $21,602.87 and a period of performance extending through June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract provides the U.S. Department of Defense with XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $17,309.80 and a period of performance through April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and sole awardee on this delivery order, which is issued under...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of XIFAXAN 550 mg tablets, a specialty pharmaceutical product, with a ceiling value of $16,486.13 and a period of performance through April 9, 2024. The contract has no set-aside designation and was awarded as a firm fixed price delivery order....